Skip to main content
. 2010 Dec;161(7):1444–1454. doi: 10.1111/j.1476-5381.2010.00934.x

Table 2.

Heart rate (HR), QT interval (QT), QTcV interval (QTcV), mechanical systole (QLVPend) and electro-mechanical window (EMw) before and after HMR1556 (maximal 1.5 mg·kg−1 i.v.) and isoprenaline (2.5 µg·kg−1 i.v) in anaesthetized dogs (n = 20)

HR (b.p.m.) QT (ms) QTcV (ms) QLVPend (ms) EMw (ms) TdP (%)
Baseline 73 ± 3 252 ± 6 265 ± 5 339 ± 8 87 ± 7 0
HMR1556 75 ± 5 319 ± 11 330 ± 10 348 ± 10 28 ± 12 0
Isoprenaline 160 ± 9 310 ± 8 362 ± 8 200 ± 6 −109 ± 6 100
Saline 153 ± 12 369 ± 13 422 ± 13 223 ± 8 −147 ± 20 100
Mexiletine 152 ± 15 301 ± 29 352 ± 26 175 ± 5 −126 ± 27 100
Atenolol 108 ± 12 316 ± 21 353 ± 16 293 ± 11 −23 ± 19 0
Verapamil 159 ± 26 255 ± 9 304 ± 4 240 ± 24 −16 ± 17 0

After induction of Torsade de Pointes (TdP), dogs were defibrillated and treated with saline (1 mL·kg−1 i.v.; n = 5), mexiletine (5 mg·kg−1 i.v. n = 5), atenolol (0.5 mg·kg−1 i.v.; n = 5) or verapamil (0.4 mg·kg−1 i.v. n = 5).

Values are expressed as mean ± SEM.

Intergroup comparisons:

P < 0.05; ANOVA/Dunnett's test (two-sided, unpaired).